אורבניל 2 ג'

Country: Israel

Language: Hebrew

Source: Ministry of Health

Active ingredient:

CLOXACILLIN AS SODIUM

Available from:

SALOMON,LEVIN & ELSTEIN LTD

ATC code:

J01CF02

Pharmaceutical form:

אבקה להכנת תמיסה לזריקה

Composition:

CLOXACILLIN AS SODIUM 2 G/VIAL

Administration route:

תוך-שרירי, תוך-ורידי

Prescription type:

מרשם נדרש

Manufactured by:

SANDOZ GmbH, AUSTRIA

Therapeutic group:

CLOXACILLIN

Therapeutic area:

CLOXACILLIN

Therapeutic indications:

For the treatment of infections caused by penicillinase-producing staphylococci. Because of the high incidence of staphylococcal isolates resistant to penicillin G both within and outside the hospiral environment . Orbenil is recommended as initial therapy in patients with suspected staphylococcal infections. Orebenil is also effective in the treatment of other commonly encountered Gram-positive coccal infections.Typical indications include: - respiratory tract infections such as pneumonia and sinusitis - infected wounds and burns - osteomyelitis and septic arthritis - other infections due to staphylococci (including penicillin-resistant strains) such as septicemia endocarditis enterocolitis and urinary tract infections.

Authorization date:

2011-11-30